LANXESS stock slips to EUR 13.13 before Xetra, down 0.53%
Published on 11/13/2026 at 08:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSPremarket Move and Q3 Signals
- LANXESS develops, manufactures and markets chemical intermediates, additives and consumer protection products.
- The company is pursuing a transformation toward higher-margin specialty chemicals.
- Its investor calendar scheduled the Q3 2026 results and management call for November 5, 2026.
LANXESS stock traded at EUR 13.13 on Lang & Schwarz at 08:06 CET on Friday, November 13, 2026, 0.53 percent below the Xetra close of Thursday, November 12, at EUR 13.20.
The move comes after the specialty chemicals group’s third-quarter reporting cycle. LANXESS develops, manufactures and markets chemical intermediates, additives and consumer protection products. Its investor materials describe a strategy focused on specialty chemicals with higher margins and additional growth opportunities.
LANXESS listed its Q3 2026 results and an investor relations conference call with management for November 5, 2026. The company’s investor page also highlights its specialty chemicals portfolio and cost-oriented transformation. For investors, the next focus is whether pricing, portfolio measures and cost savings can continue to support earnings while industrial demand remains uneven.
European equities are trading in the German market, where the DAX is the relevant benchmark.
More news and analyses on LANXESS stock
Source: LANXESS investor relations.
